Simultaneous AMPA/kainate receptor blockade and dopamine D(2/3) receptor stimulation in the nucleus accumbens decreases brain stimulation reward in rats

Behav Brain Res. 2005 Mar 7;158(1):79-88. doi: 10.1016/j.bbr.2004.08.010.

Abstract

Interactions between dopamine (DA) and glutamate (GLU) in the mesocorticolimbic pathway of the brain may influence motivation and reward. Previous work from this laboratory has demonstrated that alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA)/kainate receptor blockade may potentiate decreases in exploratory motor activity induced by the DA D(2/3) receptor agonist 7-OH-DPAT in the nucleus accumbens septi (NAS). This study investigated the interaction of AMPA/kainate receptor antagonists CNQX or NBQX with 7-OH-DPAT on ventral tegmental area (VTA) brain stimulation reward (BSR). Effects of these compounds, alone and combined, were measured in male Sprague-Dawley rats stereotaxically implanted with a unilateral VTA electrode and bilateral guide cannulae in the NAS core or shell subregions. Rate-frequency analysis was used to assess BSR frequency thresholds and maximum response rates of rats trained to lever-press for reinforcing electrical stimulation. When given alone, CNQX (0.5 microg), NBQX (0.5 microg), or 7-OH-DPAT (5.0 microg) did not affect BSR frequency thresholds. Co-administration of CNQX or NBQX with 7-OH-DPAT synergistically increased BSR frequency thresholds, indicative of decreased reward. These data indicate that simultaneous AMPA/kainate receptor blockade and DA D(2/3) receptor stimulation in the NAS may act synergistically to inhibit motivated behaviours such as electrical brain self-stimulation.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 6-Cyano-7-nitroquinoxaline-2,3-dione / pharmacology
  • Analysis of Variance
  • Animals
  • Behavior, Animal
  • Dopamine D2 Receptor Antagonists
  • Dose-Response Relationship, Radiation
  • Drug Interactions
  • Electric Stimulation / methods
  • Male
  • Microinjections / methods
  • Motor Activity / drug effects
  • Nucleus Accumbens / drug effects*
  • Nucleus Accumbens / physiology
  • Quinoxalines / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, AMPA / antagonists & inhibitors
  • Receptors, AMPA / physiology*
  • Receptors, Dopamine D2 / physiology*
  • Receptors, Kainic Acid / antagonists & inhibitors
  • Receptors, Kainic Acid / physiology*
  • Regression Analysis
  • Reward*
  • Tetrahydronaphthalenes / pharmacology
  • Ventral Tegmental Area / physiology*
  • Ventral Tegmental Area / radiation effects

Substances

  • Dopamine D2 Receptor Antagonists
  • Quinoxalines
  • Receptors, AMPA
  • Receptors, Dopamine D2
  • Receptors, Kainic Acid
  • Tetrahydronaphthalenes
  • 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline
  • 6-Cyano-7-nitroquinoxaline-2,3-dione
  • 7-hydroxy-2-N,N-dipropylaminotetralin